IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v15y2024i1d10.1038_s41467-024-49718-8.html
   My bibliography  Save this article

Cancer cell plasticity defines response to immunotherapy in cutaneous squamous cell carcinoma

Author

Listed:
  • Laura Lorenzo-Sanz

    (Bellvitge Biomedical Research Institute (IDIBELL))

  • Marta Lopez-Cerda

    (Bellvitge Biomedical Research Institute (IDIBELL))

  • Victoria da Silva-Diz

    (Bellvitge Biomedical Research Institute (IDIBELL)
    Rutgers University)

  • Marta H. Artés

    (Bellvitge Biomedical Research Institute (IDIBELL))

  • Sandra Llop

    (Catalan Institute of Oncology (ICO))

  • Rosa M. Penin

    (Bellvitge University Hospital/IDIBELL)

  • Josep Oriol Bermejo

    (Bellvitge University Hospital/IDIBELL)

  • Eva Gonzalez-Suarez

    (Bellvitge Biomedical Research Institute (IDIBELL)
    Spanish National Cancer Research Centre (CNIO))

  • Manel Esteller

    (Josep Carreras Leukaemia Research Institute (IJC)
    ISCIII
    Institució Catalana de Recerca i Estudis Avançats (ICREA)
    University of Barcelona (UB))

  • Francesc Viñals

    (Bellvitge Biomedical Research Institute (IDIBELL)
    University of Barcelona (UB)
    Catalan Institute of Oncology (ICO)/IDIBELL)

  • Enrique Espinosa

    (ISCIII
    Autonomous University of Madrid (UAM))

  • Marc Oliva

    (Catalan Institute of Oncology (ICO))

  • Josep M. Piulats

    (Bellvitge Biomedical Research Institute (IDIBELL)
    Catalan Institute of Oncology (ICO))

  • Juan Martin-Liberal

    (Catalan Institute of Oncology (ICO))

  • Purificación Muñoz

    (Bellvitge Biomedical Research Institute (IDIBELL))

Abstract

Immune checkpoint blockade (ICB) approaches have changed the therapeutic landscape for many tumor types. However, half of cutaneous squamous cell carcinoma (cSCC) patients remain unresponsive or develop resistance. Here, we show that, during cSCC progression in male mice, cancer cells acquire epithelial/mesenchymal plasticity and change their immune checkpoint (IC) ligand profile according to their features, dictating the IC pathways involved in immune evasion. Epithelial cancer cells, through the PD-1/PD-L1 pathway, and mesenchymal cancer cells, through the CTLA-4/CD80 and TIGIT/CD155 pathways, differentially block antitumor immune responses and determine the response to ICB therapies. Accordingly, the anti-PD-L1/TIGIT combination is the most effective strategy for blocking the growth of cSCCs that contain both epithelial and mesenchymal cancer cells. The expression of E-cadherin/Vimentin/CD80/CD155 proteins in cSCC, HNSCC and melanoma patient samples predicts response to anti-PD-1/PD-L1 therapy. Collectively, our findings indicate that the selection of ICB therapies should take into account the epithelial/mesenchymal features of cancer cells.

Suggested Citation

  • Laura Lorenzo-Sanz & Marta Lopez-Cerda & Victoria da Silva-Diz & Marta H. Artés & Sandra Llop & Rosa M. Penin & Josep Oriol Bermejo & Eva Gonzalez-Suarez & Manel Esteller & Francesc Viñals & Enrique E, 2024. "Cancer cell plasticity defines response to immunotherapy in cutaneous squamous cell carcinoma," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    • Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-49718-8
    DOI: 10.1038/s41467-024-49718-8
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-024-49718-8
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-024-49718-8?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Joyce V. Lee & Filomena Housley & Christina Yau & Rachel Nakagawa & Juliane Winkler & Johanna M. Anttila & Pauliina M. Munne & Mariel Savelius & Kathleen E. Houlahan & Daniel Mark & Golzar Hemmati & G, 2022. "Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    2. Joyce V. Lee & Filomena Housley & Christina Yau & Rachel Nakagawa & Juliane Winkler & Johanna M. Anttila & Pauliina M. Munne & Mariel Savelius & Kathleen E. Houlahan & Daniel Mark & Golzar Hemmati & G, 2022. "Author Correction: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer," Nature Communications, Nature, vol. 13(1), pages 1-2, December.
    3. Ievgenia Pastushenko & Audrey Brisebarre & Alejandro Sifrim & Marco Fioramonti & Tatiana Revenco & Soufiane Boumahdi & Alexandra Van Keymeulen & Daniel Brown & Virginie Moers & Sophie Lemaire & Sarah , 2018. "Identification of the tumour transition states occurring during EMT," Nature, Nature, vol. 556(7702), pages 463-468, April.
    4. Il-Kyu Kim & Mark S. Diamond & Salina Yuan & Samantha B. Kemp & Benjamin M. Kahn & Qinglan Li & Jeffrey H. Lin & Jinyang Li & Robert J. Norgard & Stacy K. Thomas & Maria Merolle & Takeshi Katsuda & Jo, 2024. "Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy in pancreatic ductal adenocarcinoma," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    5. Limo Chen & Don L. Gibbons & Sangeeta Goswami & Maria Angelica Cortez & Young-Ho Ahn & Lauren A. Byers & Xuejun Zhang & Xiaohui Yi & David Dwyer & Wei Lin & Lixia Diao & Jing Wang & Jonathon D. Roybal, 2014. "Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression," Nature Communications, Nature, vol. 5(1), pages 1-12, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Colin Y. C. Lee & Bethany C. Kennedy & Nathan Richoz & Isaac Dean & Zewen K. Tuong & Fabrina Gaspal & Zhi Li & Claire Willis & Tetsuo Hasegawa & Sarah K. Whiteside & David A. Posner & Gianluca Carless, 2024. "Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    2. C. Megan Young & Laurent Beziaud & Pierre Dessen & Angela Madurga Alonso & Albert Santamaria-Martínez & Joerg Huelsken, 2023. "Metabolic dependencies of metastasis-initiating cells in female breast cancer," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    3. Peter Bailey & Rachel A. Ridgway & Patrizia Cammareri & Mairi Treanor-Taylor & Ulla-Maja Bailey & Christina Schoenherr & Max Bone & Daniel Schreyer & Karin Purdie & Jason Thomson & William Rickaby & R, 2023. "Driver gene combinations dictate cutaneous squamous cell carcinoma disease continuum progression," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    4. Yael Aylon & Noa Furth & Giuseppe Mallel & Gilgi Friedlander & Nishanth Belugali Nataraj & Meng Dong & Ori Hassin & Rawan Zoabi & Benjamin Cohen & Vanessa Drendel & Tomer Meir Salame & Saptaparna Mukh, 2022. "Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis," Nature Communications, Nature, vol. 13(1), pages 1-20, December.
    5. Cécile Thirant & Agathe Peltier & Simon Durand & Amira Kramdi & Caroline Louis-Brennetot & Cécile Pierre-Eugène & Margot Gautier & Ana Costa & Amandine Grelier & Sakina Zaïdi & Nadège Gruel & Irène Ji, 2023. "Reversible transitions between noradrenergic and mesenchymal tumor identities define cell plasticity in neuroblastoma," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    6. Patrick Aouad & Yueyun Zhang & Fabio Martino & Céline Stibolt & Simak Ali & Giovanna Ambrosini & Sendurai A. Mani & Kelly Maggs & Hazel M. Quinn & George Sflomos & Cathrin Brisken, 2022. "Epithelial-mesenchymal plasticity determines estrogen receptor positive breast cancer dormancy and epithelial reconversion drives recurrence," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    7. Nastaran Mohammadi Ghahhari & Magdalena K. Sznurkowska & Nicolas Hulo & Lilia Bernasconi & Nicola Aceto & Didier Picard, 2022. "Cooperative interaction between ERα and the EMT-inducer ZEB1 reprograms breast cancer cells for bone metastasis," Nature Communications, Nature, vol. 13(1), pages 1-19, December.
    8. Moataz Reda & Worapol Ngamcherdtrakul & Molly A. Nelson & Natnaree Siriwon & Ruijie Wang & Husam Y. Zaidan & Daniel S. Bejan & Sherif Reda & Ngoc Ha Hoang & Noah A. Crumrine & Justin P. C. Rehwaldt & , 2022. "Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment," Nature Communications, Nature, vol. 13(1), pages 1-11, December.
    9. Guidantonio Malagoli Tagliazucchi & Anna J. Wiecek & Eloise Withnell & Maria Secrier, 2023. "Genomic and microenvironmental heterogeneity shaping epithelial-to-mesenchymal trajectories in cancer," Nature Communications, Nature, vol. 14(1), pages 1-20, December.
    10. Steffen Plunder & Cathy Danesin & Bruno Glise & Marina A. Ferreira & Sara Merino-Aceituno & Eric Theveneau, 2024. "Modelling variability and heterogeneity of EMT scenarios highlights nuclear positioning and protrusions as main drivers of extrusion," Nature Communications, Nature, vol. 15(1), pages 1-19, December.
    11. Il-Kyu Kim & Mark S. Diamond & Salina Yuan & Samantha B. Kemp & Benjamin M. Kahn & Qinglan Li & Jeffrey H. Lin & Jinyang Li & Robert J. Norgard & Stacy K. Thomas & Maria Merolle & Takeshi Katsuda & Jo, 2024. "Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy in pancreatic ductal adenocarcinoma," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    12. Christel F. A. Ramirez & Daniel Taranto & Masami Ando-Kuri & Marnix H. P. Groot & Efi Tsouri & Zhijie Huang & Daniel Groot & Roelof J. C. Kluin & Daan J. Kloosterman & Joanne Verheij & Jing Xu & Seren, 2024. "Cancer cell genetics shaping of the tumor microenvironment reveals myeloid cell-centric exploitable vulnerabilities in hepatocellular carcinoma," Nature Communications, Nature, vol. 15(1), pages 1-24, December.
    13. Mrinmoy Mukherjee & Herbert Levine, 2021. "Cluster size distribution of cells disseminating from a primary tumor," PLOS Computational Biology, Public Library of Science, vol. 17(11), pages 1-23, November.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-49718-8. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.